QuidelOrtho (QDEL) Long-Term Investments (2022 - 2023)
QuidelOrtho's (QDEL) quarterly Long-Term Investments came in at $7.4 million in Q4 2023, down 64.76% year-on-year from $21.0 million in Q4 2022, and down 37.82% quarter-over-quarter from $11.9 million in Q4 2023.
QuidelOrtho (QDEL) Long-Term Investments (2022 - 2023) Analysis & Trends
QuidelOrtho has disclosed Long-Term Investments across 2 years of filings, most recently posting $7.4 million for Q4 2023.
- Long-Term Investments for Q4 2023 came in at $7.4 million, down 64.76% year-over-year; the trailing twelve-month figure through Dec 2023 was $7.4 million (down 64.76% YoY), and the FY2023 annual result was $7.4 million, down 64.76% from the prior year.
- Long-Term Investments came in at $7.4 million for Q4 2023 at QuidelOrtho, down from $11.9 million in the prior quarter.
- In the past five years, Long-Term Investments ranged from a high of $37.9 million in Q1 2022 to a low of $7.4 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 1.09 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | - |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 285.60 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | - |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 166.25 Mn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | - |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | - |
| 10 | QuidelOrtho | 967.08 Mn | 826.68 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 7.40 Mn |
| Oct 1, 2023 | 11.90 Mn |
| Jul 2, 2023 | 24.70 Mn |
| Apr 2, 2023 | 33.80 Mn |
| Jan 1, 2023 | 21.00 Mn |
| Oct 2, 2022 | 20.30 Mn |
| Jul 3, 2022 | 15.20 Mn |
| Jan 2, 2022 | 37.90 Mn |